30367942|t|Amyloid-peptide beta 42 Enhances the Oligomerization and Neurotoxicity of apoE4: The C-terminal Residues Leu279, Lys282 and Gln284 Modulate the Structural and Functional Properties of apoE4.
30367942|a|Apolipoprotein E4 (apoE4), one of the three apoE isoforms, is the strongest factor for raising the risk for late-onset Alzheimer's disease (AD) and has been proposed to play a major role in AD pathogenesis. Amyloid-peptide beta 42 (Abeta42) has also been proposed to affect neuronal degeneration and AD pathogenesis, possibly by interacting with apoE. Previous studies have shown that the functions of apoE forms can be dictated by their structural and biophysical properties. Here we show that apoE4 can form SDS-stable oligomers, possibly reflecting aggregated forms, which increase following incubation of apoE4 with Abeta42. In addition, extracellular apoE4 is cytotoxic for human neuroblastoma SK-N-SH cells, while Abeta42 enhances the cytotoxicity of apoE4. Carboxyl-terminal point mutations L279Q, K282A or Q284A reduced the capacity of apoE4 to form SDS-stable oligomers, as well as its cytotoxicity, both in the absence and presence of Abeta42. Structural and thermodynamic analyses showed that all three apoE4 mutants have significantly increased alpha-helical and decreased beta-sheet content, have reduced portion of hydrophobic surfaces exposed to the solvent and have a reduced conformational stability during chemical denaturation. Overall, our data highlight a pathogenic role of apoE4 that could be linked to the capacity of the protein to form oligomeric species especially in the presence of Abeta42 and to induce cytotoxicity. Carboxyl-terminal residues L279, K282 or Q284 appear to be involved in the conformation of apoE4 that may underlie the protein's functional properties related to neurotoxicity.
30367942	57	70	Neurotoxicity	Disease	MESH:D020258
30367942	74	79	apoE4	Gene	348
30367942	105	111	Leu279	ProteinMutation	tmVar:p|Allele|L|279;VariantGroup:2;CorrespondingGene:348;CorrespondingSpecies:9606
30367942	113	119	Lys282	ProteinMutation	tmVar:p|Allele|K|282;VariantGroup:1;CorrespondingGene:348;CorrespondingSpecies:9606
30367942	124	130	Gln284	ProteinMutation	tmVar:p|Allele|Q|284;VariantGroup:0;CorrespondingGene:348;CorrespondingSpecies:9606
30367942	184	189	apoE4	Gene	348
30367942	191	208	Apolipoprotein E4	Gene	348
30367942	210	215	apoE4	Gene	348
30367942	235	239	apoE	Gene	348
30367942	310	329	Alzheimer's disease	Disease	MESH:D000544
30367942	331	333	AD	Disease	MESH:D000544
30367942	381	383	AD	Disease	MESH:D000544
30367942	423	430	Abeta42	Gene	351
30367942	465	486	neuronal degeneration	Disease	MESH:D009410
30367942	491	493	AD	Disease	MESH:D000544
30367942	537	542	apoE.	Gene	348
30367942	593	597	apoE	Gene	348
30367942	686	691	apoE4	Gene	348
30367942	701	704	SDS	Chemical	MESH:D012967
30367942	800	805	apoE4	Gene	348
30367942	811	818	Abeta42	Gene	351
30367942	847	852	apoE4	Gene	348
30367942	870	875	human	Species	9606
30367942	876	889	neuroblastoma	Disease	MESH:D009447
30367942	890	897	SK-N-SH	CellLine	CVCL:0531
30367942	911	918	Abeta42	Gene	351
30367942	932	944	cytotoxicity	Disease	MESH:D064420
30367942	948	953	apoE4	Gene	348
30367942	989	994	L279Q	ProteinMutation	tmVar:p|SUB|L|279|Q;HGVS:p.L279Q;VariantGroup:2;CorrespondingGene:348;CorrespondingSpecies:9606
30367942	996	1001	K282A	ProteinMutation	tmVar:p|SUB|K|282|A;HGVS:p.K282A;VariantGroup:1;CorrespondingGene:348;CorrespondingSpecies:9606
30367942	1005	1010	Q284A	ProteinMutation	tmVar:p|SUB|Q|284|A;HGVS:p.Q284A;VariantGroup:0;CorrespondingGene:348;CorrespondingSpecies:9606
30367942	1035	1040	apoE4	Gene	348
30367942	1049	1052	SDS	Chemical	MESH:D012967
30367942	1086	1098	cytotoxicity	Disease	MESH:D064420
30367942	1136	1143	Abeta42	Gene	351
30367942	1205	1210	apoE4	Gene	348
30367942	1487	1492	apoE4	Gene	348
30367942	1602	1609	Abeta42	Gene	351
30367942	1624	1636	cytotoxicity	Disease	MESH:D064420
30367942	1665	1669	L279	ProteinMutation	tmVar:p|Allele|L|279;VariantGroup:2;CorrespondingGene:348;CorrespondingSpecies:9606
30367942	1671	1675	K282	ProteinMutation	tmVar:p|Allele|K|282;VariantGroup:1;CorrespondingGene:348;CorrespondingSpecies:9606
30367942	1679	1683	Q284	ProteinMutation	tmVar:p|Allele|Q|284;VariantGroup:0;CorrespondingGene:348;CorrespondingSpecies:9606
30367942	1729	1734	apoE4	Gene	348
30367942	1800	1813	neurotoxicity	Disease	MESH:D020258
30367942	Association	MESH:D020258	CorrespondingGene:348;CorrespondingSpecies:9606;VariantGroup:2;tmVar:p
30367942	Association	MESH:D012967	348
30367942	Positive_Correlation	MESH:D000544	HGVS:p.Q284A;CorrespondingGene:348
30367942	Negative_Correlation	MESH:D064420	HGVS:p.Q284A;CorrespondingGene:348
30367942	Association	MESH:D020258	CorrespondingGene:348;CorrespondingSpecies:9606;VariantGroup:1;tmVar:p
30367942	Association	MESH:D000544	348
30367942	Negative_Correlation	MESH:D064420	HGVS:p.K282A;CorrespondingGene:348
30367942	Association	MESH:D009447	348
30367942	Association	MESH:D020258	CorrespondingGene:348;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
30367942	Association	MESH:D064420	CorrespondingGene:348;CorrespondingSpecies:9606;VariantGroup:1;tmVar:p
30367942	Association	348	351
30367942	Negative_Correlation	MESH:D064420	CorrespondingGene:348;CorrespondingSpecies:9606;VariantGroup:2;tmVar:p
30367942	Association	MESH:D000544	351
30367942	Association	MESH:D009410	351
30367942	Association	MESH:D064420	348
30367942	Positive_Correlation	MESH:D000544	CorrespondingGene:348;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
30367942	Association	MESH:D020258	348
30367942	Association	MESH:D000544	348
30367942	Association	MESH:D064420	348

